{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:06:32Z","timestamp":1793113592077,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ijid.2023.03.050","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T23:11:50Z","timestamp":1680736310000},"page":"108-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Evolution of Plasmodium falciparum antimalarial drug resistance markers post-adoption of artemisinin-based combination therapies in Yaounde, Cameroon"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8414-8202","authenticated-orcid":false,"given":"Peter Thelma Ngwa","family":"Niba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akindeh Mbuh","family":"Nji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Paul Kengne","family":"Chedjou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6484-1165","authenticated-orcid":false,"given":"Helle","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma Filtenborg","family":"Hocke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Innocent Mbulli","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Achonduh-Atijegbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Solange B.","family":"Evehe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Helene Munck","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2730-9847","authenticated-orcid":false,"given":"Calvino Tah","family":"Fomboh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8338-1974","authenticated-orcid":false,"given":"Liwang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6897-5459","authenticated-orcid":false,"given":"Gillian","family":"Stresman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jude D.","family":"Bigoga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Alifrangis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfred F.","family":"Mbacham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2023.03.050_bib0001","unstructured":"World Health Organization (WHO). World malaria report 2022, https:\/\/www.who.int\/publications\/i\/item\/9789240064898; 2022 [accessed 06 January 2023]."},{"key":"10.1016\/j.ijid.2023.03.050_bib0002","series-title":"Control Program (NMCP) annual report of activities","year":"2006"},{"key":"10.1016\/j.ijid.2023.03.050_bib0003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000055","article-title":"Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria","volume":"6","author":"Pearce","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2023.03.050_bib0004","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","article-title":"Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda","volume":"26","author":"Uwimana","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2023.03.050_bib0005","series-title":"World malaria report 2021","year":"2021"},{"key":"10.1016\/j.ijid.2023.03.050_bib0006","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11908-010-0099-y","article-title":"Drug-resistant malaria: the era of ACT","volume":"12","author":"Lin","year":"2010","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.ijid.2023.03.050_bib0007","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpddr.2021.06.001","article-title":"A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa","volume":"16","author":"Ndwiga","year":"2021","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.ijid.2023.03.050_bib0008","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1475-2875-12-103","article-title":"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance\/resistance in Bagamoyo district","volume":"12","author":"Malmberg","year":"2013","journal-title":"Tanzania. Malar J"},{"key":"10.1016\/j.ijid.2023.03.050_bib0009","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1038\/s41598-017-02724-x","article-title":"High throughput resistance profiling of Plasmodium falciparum infections based on custom dual indexing and Illumina next generation sequencing-technology","volume":"7","author":"Nag","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2023.03.050_bib0010","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12936-019-2894-8","article-title":"Proof of concept: used malaria rapid diagnostic tests applied for parallel sequencing for surveillance of molecular markers of anti-malarial resistance in Bissau, Guinea-Bissau during 2014\u20132017","volume":"18","author":"Nag","year":"2019","journal-title":"Malar J"},{"key":"10.1016\/j.ijid.2023.03.050_bib0011","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12936-020-03543-8","article-title":"Drug resistance markers within an evolving efficacy of anti-malarial drugs in Cameroon: a systematic review and meta-analysis (1998\u20132020)","volume":"20","author":"Niba","year":"2021","journal-title":"Malar J"},{"key":"10.1016\/j.ijid.2023.03.050_bib0012","article-title":"Effects of drug policy changes on evolution of molecular markers of Plasmodium falciparum resistance to chloroquine, amodiaquine, and sulphadoxine-pyrimethamine in the south west region of Cameroon","volume":"2018","author":"Moyeh","year":"2018","journal-title":"Malar Res Treat"},{"key":"10.1016\/j.ijid.2023.03.050_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-018-1207-3","article-title":"Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments-a WWARN individual patient data meta-analysis","volume":"17","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.ijid.2023.03.050_bib0014","first-page":"2","article-title":"Impact of drug pressure versus limited access to drug in malaria control: the dilemma","volume":"9","author":"Egwu","year":"2022","journal-title":"Medicines (Basel)"},{"key":"10.1016\/j.ijid.2023.03.050_bib0015","doi-asserted-by":"crossref","first-page":"692","DOI":"10.4269\/ajtmh.17-0763","article-title":"Impacts of antimalarial drugs on Plasmodium falciparum Drug resistance markers, Western Kenya, 2003\u20132015","volume":"98","author":"Hemming-Schroeder","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijid.2023.03.050_bib0016","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1186\/s13071-019-3753-8","article-title":"Review of malaria situation in Cameroon: technical viewpoint on challenges and prospects for disease elimination","volume":"12","author":"Antonio-Nkondjio","year":"2019","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.ijid.2023.03.050_bib0017","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1186\/s12879-016-1996-y","article-title":"Prevalence of malaria, typhoid, toxoplasmosis and rubella among febrile children in Cameroon","volume":"16","author":"Achonduh-Atijegbe","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2023.03.050_bib0018","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1475-2875-9-34","article-title":"Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy","volume":"9","author":"Mbacham","year":"2010","journal-title":"Malar J"},{"key":"10.1016\/j.ijid.2023.03.050_bib0019","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12879-022-07101-2","article-title":"Effectiveness and safety of artesunate\u2013amodiaquine versus artemether\u2013lumefantrine for home-based treatment of uncomplicated Plasmodium falciparum malaria among children 6\u2013120 months in Yaound\u00e9, Cameroon: a randomized trial","volume":"22","author":"Niba","year":"2022","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2023.03.050_bib0020","doi-asserted-by":"crossref","first-page":"565","DOI":"10.4269\/ajtmh.1995.52.565","article-title":"Pyrimethamine and Proguanil resistance-conferring mutations in Plasmodium falciparum Dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa","volume":"52","author":"Plowe","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijid.2023.03.050_bib0021","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet J"},{"key":"10.1016\/j.ijid.2023.03.050_bib0022","doi-asserted-by":"crossref","first-page":"e87991","DOI":"10.1371\/journal.pone.0087991","article-title":"Evaluation of whole genome sequencing for outbreak detection of Salmonella enterica","volume":"9","author":"Leekitcharoenphon","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2023.03.050_bib0023","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ijid.2021.04.081","article-title":"Targeted deep amplicon sequencing of antimalarial resistance markers in Plasmodium falciparum isolates from Cameroon","volume":"107","author":"L'Episcopia","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2023.03.050_bib0024","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s40249-017-0350-y","article-title":"Molecular markers for artemisinin and partner drug resistance in natural Plasmodium falciparum populations following increased insecticide treated net coverage along the slope of Mount Cameroon: cross-sectional study","volume":"6","author":"Apinjoh","year":"2017","journal-title":"Infect Dis Poverty"},{"key":"10.1016\/j.ijid.2023.03.050_bib0025","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/s12936-016-1503-3","article-title":"Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia","volume":"15","author":"Otienoburu","year":"2016","journal-title":"Malar J"},{"key":"10.1016\/j.ijid.2023.03.050_bib0026","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1128\/AAC.00024-09","article-title":"Novel Pfdhps haplotypes among imported cases of Plasmodium falciparum malaria in the United Kingdom","volume":"53","author":"Sutherland","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2023.03.050_bib0027","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijpddr.2016.08.004","article-title":"Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V","volume":"6","author":"Oguike","year":"2016","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.ijid.2023.03.050_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256343","article-title":"Antimalarial drug resistance in the Central and Adamawa regions of Cameroon: prevalence of mutations in P. falciparum crt, Pfmdr1, Pfdhfr and Pfdhps genes","volume":"16","author":"Tuedom","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2023.03.050_bib0029","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1473-3099(22)00593-X","article-title":"Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine\u2013pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study","volume":"23","author":"Beshir","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2023.03.050_bib0030","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1475-2875-13-152","article-title":"High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania","volume":"13","author":"Matondo","year":"2014","journal-title":"Malar J"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971223001297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971223001297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:12:18Z","timestamp":1761120738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971223001297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":30,"alternative-id":["S1201971223001297"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2023.03.050","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolution of Plasmodium falciparum antimalarial drug resistance markers post-adoption of artemisinin-based combination therapies in Yaounde, Cameroon","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2023.03.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}